Abstract
Recovery from pneumococcic meningitis is sufficiently rare and unusual to warrant the reporting of a single case. That sulfanilamide is the sine qua non of antistreptococcic therapy is undisputed; its use for pneumococcic infection is not yet fully established. Meakins, 1 Musser, 2 Cecil 3 and others 4 have expressed themselves as one in describing the disease as highly virulent and invariably fatal. Tripoli, 5 out of his ten years' experience at the Charity Hospital in New Orleans, reported 1 recovery in 111 cases of pneumococcic meningitis. His patients were treated with pneumococcic monovalent and polyvalent serum and with a pneumococcus vaccine. The 1 patient to recover was treated with polyvalent antimeningococcus serum by combined lumbar and cisternal puncture! Neal and Appelbaum 6 reported 14 cases of pneumococcic meningitis, with 3 recoveries. None of the patients who recovered received serum. Rosenthal 7 has shown that sulfanilamide is bacteriostatic and bactericidal for pneumococci in vitro, while it does
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Archives of Otolaryngology - Head and Neck Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
